Drugs / DPA-714
DPA-714
Trials 6
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT05656105 | Nov 2023 → Jun 2028 expected | long COVID-19 | University of Alabama at Birmingham | Recruiting | No outcome recorded |
| Phase 14 trials | ||||||
| Phase 1 | NCT04364672 | Jun 2025 → Jul 2026 | breast cancer | University of Alabama at Birmingham | Withdrawn | No outcome recorded Stop: Enrollment |
| Phase 1 | NCT04542603 | Jun 2025 → Aug 2026 | ovarian cancer | University of Alabama at Birmingham | Withdrawn | No outcome recorded Stop: Enrollment |
| Phase 1 | NCT03759522 | Feb 2019 → Apr 2028 expected | fibromyalgia, multiple sclerosis, myalgic encephalomeyelitis/chronic fatigue syndrome | University of Alabama at Birmingham | Recruiting | No outcome recorded |
| Phase 1 | NCT01009359 | Oct 2009 → Jul 2010 | — | Bayer | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT03457493 | Mar 2018 → Jun 2028 expected | Parkinson disease | University of Alabama at Birmingham | Recruiting | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DPA-714 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03457493 ↗ |
| Known as | 18F-labeled DPA-714 | “This clinical imaging sub-study will use the small molecule translocator protein (TSPO) ligand, 18F-labeled DPA-714, to visualize and quantify neuroinflammation in individuals...” NCT03457493 ↗1“This clinical study will use the small molecule translocator protein (TSPO) ligand, 18F-labeled DPA-714, to visualize and quantify neuroinflammation” NCT04364672 ↗ |
| Known as | BAY85-8102 | “F-18 DPA-714 (BAY85-8102)” NCT01009359 ↗ |
| Modality | Diagnostic / imaging agent | “the PET radiopharmaceutical \[F-18\]DPA-714” NCT03759522 ↗ |
| Route | Intravenous | “Single intervenous bolus injection” NCT01009359 ↗ |